Labotech Microscopes India Private Limited – FDA Warning Letter, Sep 12, 2013
On September 9-12, 2013, an FDA inspection of Labotech Microscopes India Private Limited in Haryana, India, revealed that their slit lamps and microscopes are adulterated under 21 U.S.C. § 351(h) due to non-conformity with Quality System (QS) regulation 21 CFR Part 820. The firm's September 23, 2013, response to the FDA 483 was deemed inadequate.
Violations include: 1. **Failure to establish and maintain procedures for finished device acceptance (21 CFR 820.80(d))**: (b)(4) out of (b)(4) Xcel 255 slit lamp testing reports showed values outside specified ranges. QSP 15, Rev. 6, lacked a mechanism for identifying non-conforming test results. The firm's response, including a revised traveler form and updated procedures, was insufficient as it did not describe a specific mechanism for identifying nonconforming product or provide evidence of evaluation for previously released Xcel 255 slit lamps with failed test results.
2. **Failure to establish and maintain procedures for design changes (21 CFR 820.30(i))**: Design changes, such as those for the mount projection lens (Nonconformance (b)(4)) and the (b
- Inspection date
- September 12, 2013
- Product type
- Devices
ID · c1682f25-13a1-44d6-8f98-67d2b033da81
Full citation text and observation details available on the Dashboard.
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.